Easton Pharmaceuticals Inc. Announces Medical Marijuana

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Easton Pharmaceuticals Inc. Announces Medical Marijuana Facility Buildout Nears Completion as per MMPR Health Canada Guidelines Prior to Inspection Towards Obtaining MMJ Growers License

TORONTO, ON--(Marketwired - Jul 1, 2014) - Easton Pharmaceuticals Inc. ( OTC : EAPH ) a specialty pharmaceutical company provides status update on its medical marijuana initiative.

Easton Pharmaceuticals Inc. announces that as per updates it has received, site facility build-out as mandated per health Canada MMPR guidelines are near completion and soon ready for the scheduling of a new inspection on MMJ property where Easton holds exclusive option to purchase up to 50% ownership interest in private MMPR medical marijuana grower located in Ontario, Canada. The private MMJ Company has nearly completed the process of finalizing all Health Canada site facility build-out requirements and continues to remain confident that an inspection by Health Canada will ultimately result in full approval of a Medical Marijuana Growers License. It is believed that only a lighting issue was the main impediment which needed to be addressed. Currently, only 13 companies have received medical marijuana growers' licensees under the new MMPR system that went into effect on April 1 st of this year. Health Canada has provided conservative revenue guidance to the profitability of the new MMPR system which can be viewed on its website. Easton has received many inquiries for disclosure and details of the private company, however the company at this point is unable to provide any names or further information that would adversely affect the license which has been the case with other US based companies in similar type circumstances. No other updates including which town the facility is located can be provided.

In other news, Easton has closed on an agreement on another medical marijuana initiative and will shortly make a formal announcement along with other updates on its other products and business initiatives.

About Easton Pharmaceuticals

Easton Pharmaceuticals is a specialty pharmaceutical company involved in various pharmaceutical sectors that owns, designs, develops, and markets topically-delivered drugs and therapeutic / cosmetic healthcare products, focused on cancer and other health issues related towards male and female sexual dysfunction, wound healing, pain, motion sickness, scar and stretch marks, cellulite, varicose veins and other conditions. The company is also endeavoring to enter other potentially lucrative industries such as medical marijuana. The company's gel formulation is thought to be an innovative and unique transdermal delivery system. Easton Pharmaceuticals' product " VIORRA" is an over-the-counter, topical daily use product and aid for the treatment to restore and improve vaginal moisture and elasticity which is believed to have a positive effect on women's sexual desire and arousal, FSAD (Female Sexual Arousal Disorder); the world market for these female conditions is conservatively estimated to be in the billions.

For More Information Visit: http://www.eastonpharmaceuticalsinc.com

Safe Harbor This news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding of discussion, the words "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. There are no guarantees or assurances that any proposals, initiatives or negotiations will result in what the company had originally intended. Any investment made into Easton Pharmaceuticals would be classified as speculative and risky. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.

Contact: Carla Pepe Easton Pharmaceuticals Inc. Tel: +1(416) 619-0291 Tel: +1(347) 284-0192 Email: info@eastonpharmaceuticalsinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SKINformed Bets on Skin Longevity Over Quick Fixes

Updated Category News Views 59

Wrinkle panic has been a very profitable racket for a long time, and SKINformed is trying to sidestep it. The physician-founded skincare brand is planting its flag on “SKINgevity,” a term it uses to describe long-term skin health rather than a frantic hunt for an overnight rewind. That is a sensible read on where beauty consumers appear to be headed: less appetite for...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 80

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
Visa CEDP Data Gaps Are Quietly Hammering Merchants

Updated Category News Views 89

Somewhere between a checkout button and settlement, an awful lot of money is apparently falling through a trapdoor. Verisave and Canyon Payments say 93% of the 180 merchant accounts they reviewed during one month missed Visa Commercial Enhanced Data Program discounts they could have received. The claimed savings left on the table topped $800,000 for that group in that...

Continue Reading
Fayetteville Auction Puts Two Retail Sites Into Play

Updated Category News Views 77

Two lots staring across Sycamore Dairy Road are about to get a public price tag, and that is usually where the real estate story stops being polite. Iron Horse Auction Co. plans to sell a commercial showroom at 3618 Sycamore Dairy Road and a former batting cage facility at 3701 Sycamore Dairy Road through an online-only auction closing Dec. 9 beginning at 2 p.m. They sit...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 104

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 108

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
Vision Marine's Cash Cleanup Meets a Hard Reality Ahead

Updated Category News Views 117

A boat dealer slashing debt by $27.5 million deserves a nod, even when the rest of the ledger still makes your eyebrows climb. Vision Marine Technologies turned fiscal 2026 into a working-capital cleanup job: inventory came down hard, floor-plan financing nearly vanished, and operating cash flow finally turned positive. For NASDAQ:VMAR, that is real progress. It is not,...

Continue Reading
Carnival Maps a Longer, Broader Bet on Cruise Demand

Updated Category News Views 16

A cruise operator does not order ships for 2035 because it is feeling timid. Carnival is laying out a long runway of hardware, private-destination capacity and onboard-to-onshore spending hooks, all aimed at keeping guests inside its ecosystem longer. For NYSE:CCL, this is not a next-quarter story. It is a very public statement that management sees enduring appetite for...

Continue Reading
MemorialCare Adds AI Guardrails for Hidden Aneurysms

Updated Category News Views 31

A brain scan ordered for one reason can suddenly expose a risk nobody knew was sitting there. That is the sober promise behind MemorialCare Neuroscience Institute's rollout of Rapid Aneurysm, an artificial-intelligence tool embedded in qualifying CTA and MRA brain scans across its inpatient and outpatient network. MemorialCare says it is the first health system in Los...

Continue Reading
Dar Global’s $700M Qatar Bet Leans on Trump Branding

Updated Category News Views 29

Luxury property launches rarely arrive quietly, and this one came wrapped in Palm Beach ceremony, championship golf and a very loud brand name. Dar Global has formally introduced Trump International Simaisma, Qatar, a QAR 2.5 billion development—about $700 million—alongside The Trump Organization. That is a meaningful chunk of real estate ambition, not a little side...

Continue Reading

Top 5 Most Recently Viewed Articles

Join SeaStar Medical's CEO for Exciting Insights on Benzinga

Updated Category News Views 157

Join the CEO of SeaStar Medical on Benzinga All Access SeaStar Medical Holding Corporation (Nasdaq: ICU), recognized for its innovative approach in the healthcare sector, is proud to announce an exciting event featuring its CEO, Eric Schlorff. The event, scheduled for today, promises to be a significant moment for those interested in advancements in treatments for...

Continue Reading
E-Commerce Fuels Surge in Europe's Logistics Market Growth

Updated Category News Views 220

Surge in Europe's Logistics Market Driven by E-Commerce The logistics market in Europe is poised for remarkable growth, projected to expand by approximately USD 48.4 billion between 2025 and 2029. This growth trajectory, which reflects a compound annual growth rate (CAGR) of 3.4%, is predominantly fueled by the booming e-commerce sector. As consumer behaviors shift to...

Continue Reading
Procept Bio's 18% Dive: Unpacking Fraud Allegations

Updated Category News Views 64

Procept's Plunge: Not Your Average Market Tumble When a stock takes an 18% nosedive, it’s like ringing alarm bells down Wall Street. That’s exactly what happened with Procept BioRobotics Corporation (NASDAQ:PRCT), when it found itself knee-deep in controversies over alleged shady financial practices. The Allegations: Inflated Sales and Bulk Orders Procept allegedly...

Continue Reading
Key Outcomes from AB Akola Group's Latest Shareholder Meeting

Updated Category News Views 219

AB Akola Group's Extraordinary General Meeting Insights The Extraordinary General Meeting of AB Akola Group brought together shareholders to discuss various important agendas concerning the company's future. With a total shareholding of 167,170,481 shares, of which 166,566,819 held voting rights, the company witnessed an engaging assembly of its stakeholders. Major...

Continue Reading
GO Residential REIT Secures New Financing for Growth and Flexibility

Updated Category News Views 230

Enhancing Financial Stability: GO Residential REIT's New Financing GO Residential Real Estate Investment Trust (REIT) is thrilled to announce the successful refinancing of its prestigious property, One East River Place. This strategic move is designed to unlock significant liquidity and enhance the REIT's financial flexibility. The refinancing involves a new five-year...

Continue Reading